
Market close: US tariff threats rattle sharemarket heavyweight Fisher & Paykel Healthcare
Investors are trying to figure out what Trump's policies will mean for the markets.
Investors are trying to figure out what Trump's policies will mean for the markets.
Holidaying in the Bay of Islands helps us 'look ahead with clarity and excitement'.
Greatest legacy with wife Merle is 'to provide a good example to children and grandchildren'.
The finance industry also wants to make it easier for firms to list on the stock exchange.
Turners Automotive provided the local index with more confidence and strength.
The local market was directionless as it snapped its positive start to the week.
The New Zealand sharemarket reached its highest level in a month.
Head of a $51b wealth firm says changes are needed.
Life after the $1.5 billion firm's NZX delisting.
OPINON: Whether a stronger currency is good or not depends on your perspective.
Kathmandu owner facing troubles hopes former Nike executive can help.
Trade in a2 Milk shares has gone on hold pending an announcement.
Fonterra gave the sharemarket, and the economy, some heart with a strong financial result.
The New Zealand sharemarket posted its third successive fall.
The individual appeared in the Auckland District Court today.
Contact says it wants a more diversified, resilient and efficient business.
Two advisers listed in a Du Val document told PwC they did not have any involvement.
Offer is 34% above the last trading price, Empire's statement said.
The market bounced back, following offshore movements.
Is this our economy's minerals moment?
NZ sharemarket falls more than 1%.
The New Zealand sharemarket took a breather after a string of positive days.
The decision would impact the prices consumers pay for fibre.
The S&P/NZX 50 Index turned around after the OCR was left on hold at 5.5%.
Auditor could not form an opinion on financial statements due to lack of evidence.
Some professional directors collect more than $500,000 in annual fees.
Auditor could not form an opinion on financial statements due to lack of evidence.